The enormous cost caused by mental illnesses is due to the high incidence and chronicity of some of them, as well as to the low efficacy of the drugs used for their treatment. The Therapeutic Innovation programme is a transversal programme with high quality and international visibility and channels CIBERSAM's efforts in the identification of new targets and therapeutic strategies in order to improve existing treatments. The programme integrates basic and clinical groups and develops translational and back-translational research, also working on the improvement of experimental models of mental illness. The programme has a long tradition in the identification and development of new therapeutic strategies, both pharmacological and non-pharmacological.
Main Researcher | Consortium Institution | Regions | Details |
---|---|---|---|
Esther Berrocoso Dominguez | Universidad de Cádiz. Facultad de Medicina | Andalucía | View group |
Benedicto Crespo Facorro | Hospital Universitario Marqués de Valdecilla | Cantabria | View group |
Eduard Vieta Pascual | Hospital Clínico y Provincial de Barcelona | Cataluña | View group |
Juan Salvador Nácher Roselló | Universidad de Valencia | C. Valenciana | View group |
José Javier Meana Martínez | UPV Universidad del País Vasco/EHU | País Vasco | View group |
Juan Carlos Leza Cerro | U.C.M. Facultad de Medicina | Madrid | View group |
Manuel Desco Menéndez | Hospital General Universitario Gregorio Marañón | Madrid | View group |
Analía Bortolozzi Biasoni | Instituto de Investigaciones Biomédicas de Barcelona | Cataluña | View group |
Diego José Palao Vidal | Corporación Sanitaria Parc Taulí- Fundación I3PT | Cataluña | View group |